A graphene quantum dot (GQD)-based nanocarrier was developed, and labeled with Herceptin (HER) and beta-cyclodextrin (β-CD), to target and treat HER2-overexpressing breast cancer. The gene discussed is ERBB2; the disease is breast cancer.